KR890003392A - 영양 보강물 - Google Patents

영양 보강물 Download PDF

Info

Publication number
KR890003392A
KR890003392A KR1019880010734A KR880010734A KR890003392A KR 890003392 A KR890003392 A KR 890003392A KR 1019880010734 A KR1019880010734 A KR 1019880010734A KR 880010734 A KR880010734 A KR 880010734A KR 890003392 A KR890003392 A KR 890003392A
Authority
KR
South Korea
Prior art keywords
lithium
physiologically acceptable
salt
compound
fatty acid
Prior art date
Application number
KR1019880010734A
Other languages
English (en)
Other versions
KR970000043B1 (ko
Inventor
프레데릭 호로빈 데이비드
Original Assignee
프레데릭 호로빈 데이비드
에파몰 홀딩스 피엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프레데릭 호로빈 데이비드, 에파몰 홀딩스 피엘씨 filed Critical 프레데릭 호로빈 데이비드
Publication of KR890003392A publication Critical patent/KR890003392A/ko
Application granted granted Critical
Publication of KR970000043B1 publication Critical patent/KR970000043B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/06Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Pest Control & Pesticides (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Agronomy & Crop Science (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

영양 보강물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (14)

  1. 필수 무기질을 결핍과 관련된 질병을 퇴치하는데 사용하기 위한 영양 보강물의 제조에 있어서 생리적으로 허용되는 리튬 화합물의 용도.
  2. 제1항에 있어서, 탄산리튬, 시트르산 리튬, 염화리튬, 숙신산 리튬, 황산리튬, 살리실산 리튬, 아세틸 살리실산 리튬 및 오로트산 리튬 중에서 선택된 리튬염의 용도.
  3. 제1항 또는 2항 중 어느 하나의 항에 있어서, 비경구 또는 장내 영양 보강물 제조를 위한 용도.
  4. 생리적으로 허용되는 리튬 화합물을 함유한 비경구 또는 장내 영양액으로 되는 영양 보강물.
  5. 4개 이상의 비타민 또는 무기질 및 임의로 적어도 1개의 생리적으로 허용되는 담체 또는 부형제와 함께 생리적으로 허용되는 리튬 화합물을 함유한 멸균 조성물로 되는 영양 보강물.
  6. 제5항에 있어서, 비타민 A, Bi, B2, B3, B6, B12, C, D 및 E 및 생리적으로 허용되는 칼슘, 구리, 아연, 망간 및 철 화합물로 되는 군 중에서 선택된 4개 이상의 필수 비타민 또는 무기질로 되는 보강물.
  7. 제4항 내지 6항 중 어느 하나의 항에 있어서, 리튬 1ppb 내지 10중량%로 되는 보강물.
  8. 리튬을 1ppb 내지 1중량% 함유하는 정도로 생리적으로 허용되는 리튬 화합물이 포함된 식품 베이스로 되는 영양 보강물.
  9. 제4항 내지 8항 중 어느 하나의 항에 있어서, 탄산리튬, 시트르산 리튬, 염화리튬, 숙신산 리튬, 황산리튬, 살리살산 리튬, 아세틸 살리살산 리튬 및 오로트산 리튬으로 되는 보강물.
  10. 제4항 내지 9항 중 어느 한 하나의 항에 있어서, 1개 이상의 필수 지방산 또는 생리적으로 허용되는 그의 염으로 되는 보강물.
  11. 제10항에 있어서, 적어도 1개의 리튬, 나트륨 또는 칼슘 필수 지방산 염을 함유하는 보강물.
  12. 제10항 또는 11항 중 어느 하나의 항에 있어서, 적어도 1개의 n-3 필수 지방산 또는 그의 염 및 적어도 1개의 n-6 필수 지방산 또는 그의 염을 함유하는 보강물.
  13. 알코올 중독의 치료 방법에서 사용되는 시약의 제조를 위한 생리적으로 허용되는 리튬 화합물의 용도.
  14. 복합 피부의 치료방법에서 사용되는 시약의 제조를 위한 생리적으로 허용되는 리튬 화합물의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880010734A 1987-08-25 1988-08-24 영양 보강물 KR970000043B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878719988A GB8719988D0 (en) 1987-08-25 1987-08-25 Chemical compounds
GB8719988 1987-08-25

Publications (2)

Publication Number Publication Date
KR890003392A true KR890003392A (ko) 1989-04-14
KR970000043B1 KR970000043B1 (ko) 1997-01-04

Family

ID=10622744

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880010734A KR970000043B1 (ko) 1987-08-25 1988-08-24 영양 보강물

Country Status (12)

Country Link
EP (1) EP0305097B1 (ko)
JP (1) JPS6483021A (ko)
KR (1) KR970000043B1 (ko)
AT (1) ATE96327T1 (ko)
AU (1) AU613076B2 (ko)
CA (1) CA1332358C (ko)
DE (1) DE3885212T2 (ko)
DK (1) DK172405B1 (ko)
GB (1) GB8719988D0 (ko)
IE (1) IE61750B1 (ko)
NZ (1) NZ225909A (ko)
ZA (1) ZA886322B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222080A (en) * 1988-08-15 1990-02-28 Efamol Holdings Nutritional compositions comprising polyunsaturated fatty acid salts
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
GB9916536D0 (en) * 1999-07-14 1999-09-15 Scarista Limited Nutritional or pharmaceutical compositions
CA2390510A1 (en) * 1999-11-10 2001-05-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw (Vib) Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US20090148541A1 (en) * 2007-10-16 2009-06-11 Duke University Compositions and methods for the treatment of seborrhea
EP2371372A1 (en) 2010-04-01 2011-10-05 Anrold Forbes Methods of promoting appetite suppression using alkali metals
DE102012103096A1 (de) * 2012-04-11 2013-10-17 Eberhard-Karls-Universität Tübingen Universitätsklinikum Prophylaxe und Behandlung einer Gefäßkalzifizierung
WO2016104671A1 (ja) * 2014-12-26 2016-06-30 株式会社明治 食物繊維を含む補充液
CA2978680A1 (en) 2015-03-04 2016-09-09 Arnold Forbes Compositions and methods for treating drug addiction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE886050A (fr) * 1980-11-06 1981-03-02 Beijns Charles A L Composition absorbable a base d'oligo-elements, son procede de preparation et son utilisation
US4328243A (en) * 1981-04-07 1982-05-04 Horrobin David F Manic-depressive illnesses
US4386072A (en) * 1981-06-26 1983-05-31 Horrobin David F Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
CA1257131A (en) * 1984-07-27 1989-07-11 John Y. Park Total parenteral and enteral nutrition composition
US4582709A (en) * 1985-02-08 1986-04-15 Warner-Lambert Company Chewable mineral supplement
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
DE3885212D1 (de) 1993-12-02
ZA886322B (en) 1989-05-30
DK469488D0 (da) 1988-08-22
ATE96327T1 (de) 1993-11-15
KR970000043B1 (ko) 1997-01-04
NZ225909A (en) 1992-04-28
EP0305097B1 (en) 1993-10-27
EP0305097A3 (en) 1989-04-19
JPS6483021A (en) 1989-03-28
CA1332358C (en) 1994-10-11
EP0305097A2 (en) 1989-03-01
AU2147988A (en) 1989-03-02
IE61750B1 (en) 1994-11-30
DE3885212T2 (de) 1994-04-07
DK172405B1 (da) 1998-05-25
AU613076B2 (en) 1991-07-25
DK469488A (da) 1989-02-26
GB8719988D0 (en) 1987-09-30
IE882578L (en) 1989-02-25

Similar Documents

Publication Publication Date Title
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
Kondo et al. Presence and formation of cobalamin analogues in multivitamin-mineral pills.
KR890003392A (ko) 영양 보강물
TR200000021T2 (tr) Bağırsak hücreleri tarafından minerallerin emilmesi.
MX9202105A (es) Complementos de calcio y vitamina d combinados.
MY107865A (en) Calcium and trace mineral supplements.
EP0034034A1 (en) Nutrient composition
ES8705748A1 (es) Un procedimiento para la preparacion de una formula alimenticia baja en hidratos de carbono y alta en grasas.
GB1493993A (en) Dietary supplement and dietary methods employing said supplement for the treatment of obesity
IL70117A (en) Animal feed containing an aqueous solution of l-lysine as a supplement
KR890003391A (ko) 칼슘 보충제
AU1971888A (en) Nutrient mixture intended for the elderly
PL337516A1 (en) Zinc and lynolic acid containing nourishment
ATE32650T1 (de) Getraenk, enthaltend fructose, vitamin c, chinin und/oder deren austauschstoffe.
Lönnerdal et al. Selenium supplementation of infant formula: uptake and retention of various forms of selenium in suckling rats
RU2164764C1 (ru) Биологически активная добавка к пище
NZ218398A (en) A method of increasing the fat content of the colostrum or milk of a lactating sow
ES2023391B3 (es) Polvos adecuados para bebidas.
ATE186817T1 (de) Herstellung von fettsäuresalz-diätprodukten
Jelliffe et al. Commentary: Recommended dietary allowances for infants
NZ285593A (en) An enteral nutritional product containing casein that is sufficient to inhibit infection of mammalian cells by human rotavirus
RU93058335A (ru) Добавки, содержащие кальций и витамин д, напиток
Scott Nutrition of the Young Chick1
KR890003803A (ko) 스트렙토그라민 b/금속 착화합물, 이의 제조 방법 및 가축의 영양 공급을 위한 용도
Gammie et al. Egg Binding in a Western Painted Turtle

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee